Retina topics most-downloaded papers in Ophthalmology
WAIKOLOA, Hawaii — Retina topics overwhelmingly topped the list of Ophthalmology articles that generate interest, according to a presentation.
George B. Bartley , MD, editor-in-chief of the journal, along with his colleagues on the editorial board, related what they considered to be the year’s most “intriguing” papers from 2015.

George B. Bartley
“We do watch our downloads pretty carefully to see what people are interested in and what they’re reading,” Bartley said.
Andrew Schachat, MD, a retina specialist and editorial board member, chose papers “that are most important for you to know about as a non-retina specialist, and if you’re a retina specialist, you know about them.”

Andrew Schachat
As one of those articles for 2015, Schachat chose “Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol,” a study that found bevacizumab and ranibizumab to be equivalent. Other studies that have compared the two drugs – CATT, IVAN, GEFAL, MANTA – all used a monthly treatment or an as needed treatment, which involved seeing the patient every month.
“The reason [LUCAS] is an important paper is it uses the treatment timing, or recipe, that most of us actually use ... a treat-and-extend protocol,” Schachat said. – by Patricia Nale, ELS
References:
Bartley GB. The year’s most intriguing papers from Ophthalmology. Presented at: Hawaiian Eye; Jan. 17, 2016; Waikoloa, Hawaii.
Disclosure: Bartley and Schachat report no relevant financial disclosures.